Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Tie2 regulates endocardial sprouting and myocardial trabeculation
Xianghu Qu, Cristina Harmelink, H. Scott Baldwin
Xianghu Qu, Cristina Harmelink, H. Scott Baldwin
View: Text | PDF
Research Article Cardiology Development

Tie2 regulates endocardial sprouting and myocardial trabeculation

  • Text
  • PDF
Abstract

The ang1-tyrosine kinase with immunoglobulin-like and EGF-like domains 2 (Tie2) pathway is required for normal vascular development, but its molecular effectors are not well-defined during cardiac ontogeny. Here, we show that endocardial-specific attenuation of Tie2 results in midgestation lethality due to heart defects associated with a hyperplastic but simplified trabecular meshwork (fewer but thicker trabeculae). Reduced proliferation and production of endocardial cells following endocardial loss of Tie2 results in decreased endocardial sprouting required for trabecular assembly and extension. The hyperplastic trabeculae result from enhanced proliferation of trabecular cardiomyocytes, which is associated with upregulation of bone morphogenetic protein 10, increased retinoic acid (RA) signaling, and extracellular signal-regulated protein kinases 1 and 2 hyperphosphorylation in the myocardium. Intriguingly, myocardial phenotypes in conditional knockout hearts could be partially rescued by inhibiting in utero RA signaling with pan-RA receptor antagonist BMS493. These findings reveal 2 complementary functions of endocardial Tie2 during ventricular chamber formation: ensuring normal trabeculation by supporting endocardial cell proliferation and sprouting and preventing hypertrabeculation via suppression of RA signaling in trabecular cardiomyocytes.

Authors

Xianghu Qu, Cristina Harmelink, H. Scott Baldwin

×

Figure 4

Endocardial attenuation of Tie2 results in decreased EC number and proliferation.

Options: View larger image (or click on image) Download as PowerPoint
Endocardial attenuation of Tie2 results in decreased EC number and proli...
(A–F) Dual immunostaining of Tie2+/fl (A and C) and Tie2-cko (B and D) heart sections for Erg (red) and endomucin (green) at E13.0 reveals a significant decrease in Erg-positive EC number in the mutant ventricles following endocardial loss of Tie2. (C and D) Boxed regions in A and B are enlarged, and aggregations of ECs in dilated sproutings (arrow) are often observed in Tie2-cko endocardium. Nuclei are counterstained with DAPI (blue). (G) Quantification of total Erg/endomucin–positive cells indicated a gradual loss of ECs in the mutant endocardium, significant from E9.5. (H–K) Dual immunostaining of control (H and J) and Tie2-cko (I and K) heart sections for BrdU (red) and Erg (green) at E10.5. The cells positive for both BrdU and Erg represent proliferating ECs (arrows), which are decreased in the mutant ventricles. (L) Quantification of BrdU/Erg–positive cells as a percentage of total Erg-positive cells in endocardium indicated that Tie2-cko displayed lower proliferation rates of ECs at E10.5 and at E11.5. Scale bars: C and D, 100 μm; others, 50 μm. A representative of more than 10 images was chosen for each panel (n ≥ 5 per group). *P < 0.05; **P < 0.01, 1-way ANOVA.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts